Wellgistics Health, INC. (WGRX) — SEC Filings

Overview

Wellgistics Health, INC. (WGRX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 4 filed on Apr 24, 2026: On March 31, 2026, Ajjarapu Surendra K. reported a change in beneficial ownership of securities for Wellgistics Health, Inc. The filing details transactions related to this change, though specific dollar amounts and the nature of the transactions are not provided in this excerpt.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 1 bearish, 46 neutral, 3 mixed. The dominant filing sentiment for Wellgistics Health, INC. is neutral.

Filing Type Overview

Wellgistics Health, INC. (WGRX) has filed 2 4, 30 8-K, 1 PRER14C, 1 8-K/A, 3 10-Q, 9 S-1/A, 3 S-1, 1 10-K with the SEC between Jul 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (50)

• 4 Filing — 4 · Apr 24, 2026
• Wellgistics Health Inc. Insider Ownership Change Reported — 4 · Apr 24, 2026 Risk: low
  On March 31, 2026, Ajjarapu Surendra K. reported a change in beneficial ownership of securities for Wellgistics Health, Inc. The filing details transactions rel
• Wellgistics Health Files 8-K: Agreements and Equity Sales — 8-K · Apr 7, 2026 Risk: medium
  On April 1, 2026, Wellgistics Health, Inc. entered into a material definitive agreement, potentially creating a direct financial obligation or an off-balance sh
• Wellgistics Health Files PRER14C for Non-Voting Shareholder Action — PRER14C · Mar 25, 2026
  Wellgistics Health, Inc. (CIK: 0002030763) filed a PRER14C on March 25, 2026, indicating an upcoming shareholder action that does not require a vote. This filin
• 8-K Filing — 8-K · Dec 19, 2025
• 8-K Filing — 8-K · Dec 16, 2025
• Wellgistics Health, Inc. Files 8-K — 8-K · Dec 8, 2025 Risk: low
  Wellgistics Health, Inc. filed an 8-K on December 8, 2025, reporting a name change from Danam Health, Inc. to Wellgistics Health, Inc. effective July 17, 2024.
• Wellgistics Health Files 8-K Current Report — 8-K · Dec 5, 2025 Risk: low
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on December 5, 2025, reporting events on December 4, 2025. The filing is a current report un
• Wellgistics Health Files 8-K/A Amendment — 8-K/A · Nov 26, 2025 Risk: low
  Wellgistics Health, Inc. filed an amendment (8-K/A) on November 26, 2025, related to events on November 24, 2025. The filing concerns a material definitive agre
• Wellgistics Health Enters Material Definitive Agreement — 8-K · Nov 25, 2025 Risk: medium
  On November 24, 2025, Wellgistics Health, Inc. (formerly Danam Health, Inc.) entered into a material definitive agreement. The company, incorporated in Delaware
• Wellgistics Health Files 8-K on Financials — 8-K · Nov 20, 2025 Risk: low
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on November 20, 2025, reporting results of operations, financial condition, and providing a
• WGRX Revenue Soars, But Net Loss Explodes Amid Soaring G&A Costs — 10-Q · Nov 19, 2025 Risk: high
  Wellgistics Health, Inc. (WGRX) reported a significant increase in net revenues for the nine months ended September 30, 2025, reaching $21,667,212, a substantia
• 8-K Filing — 8-K · Nov 17, 2025
• Wellgistics Health Files 8-K — 8-K · Oct 30, 2025 Risk: low
  Wellgistics Health, Inc. filed an 8-K on October 30, 2025, reporting an event on October 24, 2025. The company, formerly known as Danam Health, Inc. until July
• Wellgistics Health, Inc. Files 8-K — 8-K · Oct 27, 2025 Risk: low
  Wellgistics Health, Inc. filed an 8-K on October 27, 2025, reporting a name change from Danam Health, Inc. on July 17, 2024. The company, incorporated in Delawa
• Wellgistics Health Files 8-K with Updates — 8-K · Oct 22, 2025 Risk: low
  Wellgistics Health, Inc. filed an 8-K on October 22, 2025, reporting events as of October 21, 2025. The filing includes a Regulation FD Disclosure, Other Events
• Wellgistics Health Files 8-K for Reg FD and Exhibits — 8-K · Oct 17, 2025 Risk: low
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on October 17, 2025, reporting events as of October 13, 2025. The filing primarily concerns
• Wellgistics Health Announces Board and Officer Changes — 8-K · Oct 10, 2025 Risk: medium
  On October 6, 2025, Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K report detailing changes in its board of directors and executive officer
• Wellgistics Health Reports Officer/Director Changes — 8-K · Oct 6, 2025 Risk: medium
  Wellgistics Health, Inc. filed an 8-K on October 6, 2025, reporting changes effective October 1, 2025. The filing indicates a departure of directors or certain
• Wellgistics Health, Inc. Signs Material Definitive Agreement — 8-K · Oct 1, 2025 Risk: medium
  On September 25, 2025, Wellgistics Health, Inc. entered into a material definitive agreement. The company, formerly known as Danam Health, Inc. until July 17, 2
• Wellgistics Launches XRP Payments, Seeks $7.5M in Equity Offering — S-1/A · Sep 22, 2025 Risk: high
  Wellgistics Health, Inc. (WGRX) is offering up to 5,357,142 shares of Common Stock and accompanying Warrants, with an assumed combined public offering price of
• Wellgistics Health Launches XRP Payments, Seeks Capital via S-1/A — S-1/A · Sep 12, 2025 Risk: high
  Wellgistics Health, Inc. (WGRX) filed an S-1/A on September 12, 2025, outlining a public offering of common stock, warrants, and pre-funded warrants. The compan
• Wellgistics Health Files 8-K — 8-K · Sep 8, 2025 Risk: low
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on September 8, 2025, reporting events as of September 5, 2025. The filing primarily concern
• Wellgistics Health (WGRX) Files 8-K with Office & Trading Info — 8-K · Aug 29, 2025 Risk: low
  On August 28, 2025, Wellgistics Health, Inc. (WGRX) filed an 8-K report. The filing confirms the company's principal executive offices are located at 3000 Baypo
• Wellgistics Health Files 8-K on Operations & Financials — 8-K · Aug 22, 2025 Risk: low
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on August 22, 2025, reporting events as of August 20, 2025. The filing pertains to results o
• Wellgistics Health Files Q2 2025 Report — 10-Q · Aug 19, 2025 Risk: low
  Wellgistics Health, Inc. filed its quarterly report for the period ended June 30, 2025. The company's common stock trades under the symbol WGRX on The Nasdaq St
• Wellgistics Health Announces Agreement Termination & Officer Changes — 8-K · Aug 14, 2025 Risk: medium
  Wellgistics Health, Inc. announced on August 8, 2025, the termination of a material definitive agreement. The company also reported changes in its board and off
• Wellgistics Health, Inc. Files 8-K for Material Agreement — 8-K · Jul 30, 2025 Risk: medium
  On July 24, 2025, Wellgistics Health, Inc. (formerly Danam Health, Inc.) entered into a material definitive agreement. The company, incorporated in Delaware wit
• Wellgistics Health Files S-1 for Public Offering, Signals Growth Ambition — S-1 · Jul 24, 2025 Risk: high
  Wellgistics Health, Inc. (WGRX) filed an S-1 on July 24, 2025, indicating its intent for a delayed or continuous public offering under Rule 415. The company, fo
• Wellgistics Health Changes Auditors Amid Revenue Recognition Dispute — 8-K · Jul 8, 2025 Risk: medium
  Wellgistics Health, Inc. announced on July 7, 2025, a change in its certifying accountant. The company has dismissed BDO USA, LLP and engaged WithumSmith+Brown,
• Wellgistics Health, Inc. Reports Name Change — 8-K · May 15, 2025 Risk: low
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on May 15, 2025, reporting a name change effective July 17, 2024. The company, incorporated
• Wellgistics Health Files Q1 2025 10-Q — 10-Q · May 12, 2025 Risk: low
  Wellgistics Health, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Danam Health, Inc. until July 17, 2024, is based in
• Wellgistics Health Files S-1 for Public Offering — S-1 · May 5, 2025 Risk: medium
  Wellgistics Health, Inc., formerly Danam Health, Inc., filed an S-1 registration statement on May 5, 2025, to register securities. The company, incorporated in
• Wellgistics Health Announces Material Agreement, Officer Changes — 8-K · Apr 24, 2025 Risk: medium
  On April 22, 2025, Wellgistics Health, Inc. (formerly Danam Health, Inc.) entered into a material definitive agreement. The company also announced the departure
• Wellgistics Health, Inc. Files 8-K, Reports Name Change — 8-K · Apr 18, 2025 Risk: low
  On April 14, 2025, Wellgistics Health, Inc. (formerly Danam Health, Inc.) entered into a material definitive agreement. The company, incorporated in Delaware wi
• Wellgistics Health Files 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Apr 11, 2025 Risk: medium
  On April 8, 2025, Wellgistics Health, Inc. (formerly Danam Health, Inc.) entered into a material definitive agreement. The company also reported on the creation
• Wellgistics Health Files 8-K on Equity Sales — 8-K · Mar 27, 2025 Risk: medium
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on March 27, 2025, reporting unregistered sales of equity securities and a Regulation FD dis
• Wellgistics Health Files 2024 10-K — 10-K · Mar 25, 2025 Risk: medium
  Wellgistics Health, Inc. filed its 2024 10-K on March 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Danam Heal
• Wellgistics Health Enters Material Definitive Agreement — 8-K · Mar 21, 2025 Risk: medium
  On March 17, 2025, Wellgistics Health, Inc. (formerly Danam Health, Inc.) entered into a material definitive agreement. The company, incorporated in Delaware wi
• Wellgistics Health: Director Change & New Agreement — 8-K · Mar 6, 2025 Risk: medium
  Wellgistics Health, Inc. announced on February 28, 2025, the departure of Director David L. Smith and the appointment of new Director Michael J. O'Brien. The co
• Wellgistics Health Enters Material Definitive Agreement — 8-K · Feb 28, 2025 Risk: medium
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) entered into a material definitive agreement on February 25, 2025. The company, incorporated in Delaware
• Wellgistics Health Files 8-K for Material Agreement — 8-K · Feb 26, 2025 Risk: medium
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on February 26, 2025, reporting a material definitive agreement. The filing also includes ot
• Wellgistics Health Files S-1/A for IPO — S-1/A · Jan 14, 2025 Risk: medium
  Wellgistics Health, Inc. filed an S-1/A amendment on January 14, 2025, for its initial public offering. The company, formerly known as Danam Health, Inc. until
• Wellgistics Health Files S-1/A Amendment 6 — S-1/A · Dec 18, 2024 Risk: medium
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an S-1/A amendment on December 18, 2024, for its initial public offering. The company, incorporated
• Wellgistics Health Files S-1/A Amendment — S-1/A · Dec 6, 2024 Risk: medium
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an S-1/A amendment on December 6, 2024, for its registration statement. The company, incorporated i
• Wellgistics Health Files IPO Amendment — S-1/A · Nov 6, 2024 Risk: medium
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an S-1/A amendment on November 6, 2024, for its initial public offering. The company, incorporated
• Wellgistics Health Files S-1/A Amendment — S-1/A · Oct 21, 2024 Risk: medium
  Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an amendment (S-1/A) on October 21, 2024, for its registration statement. The company, incorporated
• Danam Health Files S-1/A for IPO — S-1/A · Sep 27, 2024 Risk: medium
  Danam Health, Inc. filed an S-1/A amendment on September 27, 2024, for its initial public offering. The company, incorporated in Delaware, is based in Tampa, Fl
• Danam Health Files S-1/A Amendment for IPO — S-1/A · Aug 2, 2024 Risk: medium
  Danam Health, Inc. filed an S-1/A amendment on August 2, 2024, for its initial public offering. The company, incorporated in Delaware, is based in Tampa, Florid
• Danam Health Files for IPO — S-1 · Jul 22, 2024 Risk: medium
  Danam Health, Inc. filed an S-1 registration statement with the SEC on July 22, 2024, to register securities for a proposed sale. The company, incorporated in D

Risk Profile

Risk Assessment: Of WGRX's 45 recent filings, 4 were flagged as high-risk, 25 as medium-risk, and 16 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Wellgistics Health, INC.'s most recent 10-Q filing (Nov 19, 2025):

• Revenue: $21.67M
• Net Income: -$73.42M
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: $4.23M
• Operating Margin: N/A
• Total Assets: N/A
• Total Debt: N/A

Key Executives

• Ajjarapu Surendra K.
• Chief Executive Officer
• Brian Norton
• Kate L. Bechen
• Louis D. Kern
• David L. Smith
• Michael J. O'Brien
• Timothy Canning
• Robin K. Lehninger
• Ross David Carmel
• Thiago Sperce
• Ross David Carmel, Esq.
• Thiago Spercel
• Thiago Spercel, Esq.

Industry Context

The healthcare logistics and services sector is characterized by increasing demand for efficient supply chain management, driven by an aging population and advancements in medical treatments. Companies in this space face competition from established players and specialized providers, requiring significant investment in technology, infrastructure, and regulatory compliance. Trends include a focus on cold chain logistics, pharmaceutical distribution, and integrated patient support services.

Top Tags

material-agreement (11) · ipo (9) · amendment (7) · corporate-action (6) · disclosure (6) · company-name-change (6) · sec-filing (6) · name-change (5) · Emerging Growth Company (3) · registration-statement (3)

Key Numbers

• SEC Accession Number: 0001493152-26-015548 — Unique identifier for this specific SEC filing
• Net Revenues: $21.67M — Increased from $5.72M for the nine months ended September 30, 2024
• Net Loss: $73.42M — Increased from $2.52M for the nine months ended September 30, 2024
• General and Administrative Expenses: $66.21M — Increased from $2.45M for the nine months ended September 30, 2024
• Cash and Cash Equivalents: $4.23M — As of September 30, 2025, up from $1.03M at December 31, 2024
• Net Proceeds from IPO: $3.1M — Generated from the IPO on February 24, 2025
• Revenue Concentration: 14% — One customer accounted for approximately 14% of total revenue for the nine months ended September 30, 2025
• Accounts Receivable Concentration: 22% — One customer accounted for approximately 22% of gross accounts receivable as of September 30, 2025
• Loss on Debt Extinguishment: $1.35M — Incurred for the nine months ended September 30, 2025
• Interest Expense, net: $3.70M — Increased from $142,281 for the nine months ended September 30, 2024
• Shares Outstanding: 102,289,619 — As of November 19, 2025
• Assumed combined public offering price: $1.40 — Per share of Common Stock and accompanying Warrant
• Maximum shares of Common Stock offered: 5,357,142 — Number of shares offered in the public offering
• Maximum Warrants offered: 5,357,142 — Number of Warrants accompanying Common Stock or Pre-Funded Warrants
• Pre-Funded Warrant exercise price: $0.0001 — Exercise price per share for Pre-Funded Warrants

Related Companies

XRP

Frequently Asked Questions